Access the full text.
Sign up today, get DeepDyve free for 14 days.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
Rheumatology 2004;43:1065 doi:10.1093/rheumatology/keh310 Matteson EL, Weyand CM, Fulbright JW, Christianson TJH, McClelland RL and Goronzy JJ. How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to ‘non-aggressive’ DMARD treatment and perspective from a 2-yr open label trial. Rheumatology 2004;43:619-25. First published February 24, 2004, doi:10.1093/rheumatology/keh135. The authors would like to apologize for an error in the above article. It was reported that the presence of HLA-C7xx was associated with an increased likelihood of requiring methotrexate at month 24. The ‘xx’ was an internal data entry designation which has no further significance and should have been removed prior to publication. The authors regret any confusion this may have caused. Rheumatology Vol. 43 No. 8 British Society for Rheumatology 2004; all rights reserved
Rheumatology – Oxford University Press
Published: Aug 1, 2004
You can share this free article with as many people as you like with the url below! We hope you enjoy this feature!
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.